Tous Actualités
Suivre
Abonner W.O.M. World of Medicine AG

W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Management Changes
Change to the Management Board at WORLD OF MEDICINE/ New CFO assumes Management Board position effective May 1, 2005

Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.
15.04.2005
The Supervisory Board of medical device manufacturer WORLD OF
MEDICINE today appointed Andreas Schröteler to be its new Chief
Financial Officer, effective May 1, 2005. He comes to WORLD OF
MEDICINE from BDO, the leading international accounting firm, where
he served 13 years, for many years in an executive capacity as a
Senior Manager. After an extended professional engagement in the USA,
the 38 year-old is now assuming responsibility for the Departments of
Accounting, Controlling, Investor Relations, IT and Materials
Management.
Schröteler holds his graduate degree in business (Dipl. Kaufmann),
and is a certified accountant and tax advisor. Beside his
international business experience, he has expertise in the areas of
financial organization and controlling, as well as a deep knowledge
of US-GAAP and IFRS international accounting standards.
The preceding CFO, Michael Ott, has at his own wish decided against
extending his contract, which expires this year; instead he will be
pursuing a separate business engagement. The Supervisory Board today
accepted his resignation from his post on the Management Board at the
end of April 2005. Mr. Ott will resign from the Company effective May
31, 2005. He will remain available to WORLD OF MEDICINE in an
advisory capacity for the following nine months. The Supervisory
Board and Management Board wish to thank Mr. Ott for his strong
commitment and his consistently effective service. They strongly
regret his departure and offer him their best wishes in his future
personal and professional endeavors.
The Management Board
end of announcement                    euro adhoc 15.04.2005 10:30:15 

Further inquiry note:

Stefanie Gehrke
Tel.: +49 (0)30 39981 566
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing
Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Niedersächsische Börse zu Hannover / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade

Plus de actualités: W.O.M. World of Medicine AG
Plus de actualités: W.O.M. World of Medicine AG